Cargando…
Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases
We previously discovered that gut microbiota can serve as universal microbial biomarkers for diagnosis, disease activity assessment, and predicting the response to infliximab treatment for inflammatory bowel diseases (IBD). Much still remains unknown about the relationship between alterations in gut...
Autores principales: | Zhou, Youlian, He, Yan, Liu, Le, Zhou, Wanyan, Wang, Pu, Hu, Han, Nie, Yuqiang, Chen, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952524/ https://www.ncbi.nlm.nih.gov/pubmed/33718417 http://dx.doi.org/10.3389/fnut.2021.615064 |
Ejemplares similares
-
Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease
por: Guo, Xue, et al.
Publicado: (2022) -
Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice
por: He, Hanchang, et al.
Publicado: (2020) -
Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
por: Zhou, Youlian, et al.
Publicado: (2018) -
How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease?
por: Guo, Feilong, et al.
Publicado: (2021) -
Corrigendum: How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease?
por: Guo, Feilong, et al.
Publicado: (2021)